ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 904

Perinatal Characteristics, Maternal Reproductive History and Juvenile Idiopathic Arthritis: A Case-Control Study

Samantha W. Bell1, Beth A. Mueller1, J. Lee Nelson2, Parveen Bhatti1 and Susan Shenoi3, 1Epidemiology and Public Health, University of Washington, Seattle, WA, 2Immunogenetics D2-100, Fred Hutchinson Cancer Rsch, Seattle, WA, 3Pediatric Rheumatology, Seattle Children's Hospital, University of Washington, Seattle, WA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Juvenile Arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is a heterogeneous group of chronic inflammatory arthritis conditions in children with onset before 16 years of age, and is the leading cause of acquired short and long-term disability in childhood. The etiology of JIA is largely unknown, however there is increasing evidence that autoimmune diseases, including JIA, may be associated with maternal reproductive or early childhood exposures.

Methods: We conducted a case-control study of JIA cases identified at a regional children’s hospital in the Seattle-Puget Sound area, using linked birth certificate data from 1980 – 2009. Potential cases included all children <20 years with relevant ICD codes who had received inpatient or outpatient care. Their records were linked to Washington State birth records for 1980-2009 to identify those with a Washington State birth certificate (N=1,518). For comparison, control children were randomly selected in a ratio of 4:1 from the remaining birth records, frequency matched on year of birth (N=6,072). Review of medical records further refined case ascertainment based on specific clinical criteria (N=1,254) and allowed categorization of cases into JIA subtypes. Multivariable logistic regression was used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI) for the associations of JIA/JIA subtypes with maternal and early life exposures as measured in the birth certificates.

Results: Decreased ORs were observed for JIA in relation to greater maternal parity (2 prior live births, OR 0.70, 95% CI 0.58, 0.85; 4+ prior live births, OR 0.68, 95% CI 0.48, 0.97), a finding also observed for the persistent oligoarticular JIA subtype. Fewer cases (11.4%) than controls (13.3%) had a birth weight >4000 g (OR 0.81, 95% CI 0.67, 0.98). Mothers of cases (5.2%) were slightly more likely than those of controls (4.1%) to have had preeclampsia during their pregnancy (OR 1.29, 95% CI 0.96, 1.73).

Conclusion: To our knowledge, no studies to date in the United States have examined these exposures in relation to JIA. Greater maternal parity, specifically having 2 or more prior live births, was significantly associated with a decreased OR for JIA, a finding consistent with both the hygiene and microchimerism hypotheses.


Disclosure:

S. W. Bell,
None;

B. A. Mueller,
None;

J. L. Nelson,
None;

P. Bhatti,
None;

S. Shenoi,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perinatal-characteristics-maternal-reproductive-history-and-juvenile-idiopathic-arthritis-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology